MKI67 and systemic lupus erythematosus: Overall, active SLE and vax-HC ASC, the latter serving as a control for newly generated ASC, displayed a homogenous Ki-67+/HLA-DR+ phenotype, even in cells with an otherwise mature BM-like phenotype, i.e., CD19−CD138+ fraction (Pop 5).